Cargando…

Predictive approaches in inflammatory bowel disease

Detalles Bibliográficos
Autor principal:	Pinton, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841441/ https://www.ncbi.nlm.nih.gov/pubmed/34717032 http://dx.doi.org/10.1111/cts.13179

Ejemplares similares

Crohn’s disease and short bowel syndrome
por: Pinton, Philippe
Publicado: (2022)

Computational models in inflammatory bowel disease
por: Pinton, Philippe
Publicado: (2022)

Lung involvement in inflammatory bowel diseases
por: Sarıoğlu, Nurhan, et al.
Publicado: (2006)

Letter to the editor: Triclosan in patients with inflammatory bowel disease
por: Peña-Cardelles, Juan Francisco
Publicado: (2022)

Tremor in Patients with Inflammatory Bowel Disease
por: De Oliveira, Gisele R., et al.
Publicado: (2013)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

Familial inflammatory bowel diseases in Northwest Greece
por: Katsanos, Konstantinos H., et al.
Publicado: (2015)

Inflammatory Bowel Disease and the Risk of Herpes Zoster
por: Lai, Shih-Wei
Publicado: (2019)

Alterations of pulmonary function in patients with inflammatory bowel diseases
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Therapeutic drug monitoring in inflammatory bowel disease treatments
por: Wang, Meng-Yao, et al.
Publicado: (2022)

Plant-Based Diet Recommended for Inflammatory Bowel Disease
por: Chiba, Mitsuro, et al.
Publicado: (2023)

Life expectancy in patients with inflammatory bowel disease: time will tell if biologics are the answer
por: Chanchlani, Neil, et al.
Publicado: (2021)

Awareness of adverse effects of Azathioprine in patients with Inflammatory Bowel Disease – more to be done?
por: Spence, Andrew David Roy, et al.
Publicado: (2014)

Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
por: Brenner, Erica J., et al.
Publicado: (2021)

Vedolizumab Is Safe in Elderly Veteran Patients With Inflammatory Bowel Disease
por: Leung, Kenneth, et al.
Publicado: (2021)

MDR1C3435T Polymorphism and Inflammatory Bowel Disease
por: Malik, Manzoor A.
Publicado: (2015)

Comment on “Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease”
por: Lai, Wenwen, et al.
Publicado: (2018)

Extraintestinal manifestations of pediatric inflammatory bowel disease in Saudi Arabia
por: Al-Mendalawi, Mahmood D.
Publicado: (2018)

Inflammatory bowel disease and diabetes: Is there a link between them?
por: Sang, Miao-Miao, et al.
Publicado: (2022)

Urotensin II level is elevated in inflammatory bowel disease patients
por: Zhang, Yan, et al.
Publicado: (2022)

Raman spectroscopic molecular fingerprinting of biomarkers for inflammatory bowel disease
por: Buchan, Emma, et al.
Publicado: (2023)

Inflammatory Bowel Disease Patients With Coronavirus Disease 2019: The Picture Is Taking Shape
por: Papa, Alfredo, et al.
Publicado: (2021)

Inflammatory Bowel Disease: A Personalized Approach
por: Konidari, Anastasia, et al.
Publicado: (2021)

Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
por: Bacsur, Péter, et al.
Publicado: (2021)

What Might be the Cause for the Emerging Inflammatory Bowel Disease in Saudi Outpatients?
por: Qin, Xiaofa
Publicado: (2014)

Adsorptive Leukocytapheresis in Inflammatory Bowel Diseases: Our Preliminary Results are Encouraging
por: Törüner, Murat, et al.
Publicado: (2013)

The optimal time to perform an ophthalmic examination of patients with inflammatory bowel disease
por: Biancardi, Ana Luiza, et al.
Publicado: (2019)

Diet and nutrition against inflammatory bowel disease: Trick or treat(ment)?
por: Greco, Salvatore, et al.
Publicado: (2022)

Predicting Response to Vedolizumab in Inflammatory Bowel Disease
por: Meserve, Joseph, et al.
Publicado: (2020)

Initiation of subcutaneous infliximab (Remsima) therapy for the treatment of inflammatory bowel disease during the COVID-19 pandemic
por: McGoran, John, et al.
Publicado: (2021)

A novel Trmt5-deficient zebrafish model with spontaneous inflammatory bowel disease-like phenotype
por: Zhao, Qiong, et al.
Publicado: (2023)

Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach
por: Charilaou, Paris, et al.
Publicado: (2022)

Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol–thiopurine cotherapy
por: Simsek, Melek, et al.
Publicado: (2018)

African Ancestry Proportion Influences Ileal Gene Expression in Inflammatory Bowel Disease
por: Mo, A., et al.
Publicado: (2020)

Response to Comments on the CAG/CCC Position Statement on Biosimilars for Inflammatory Bowel Disease
por: Moayyedi, Paul, et al.
Publicado: (2020)

COVID-19 and Inflammatory Bowel Disease: Questions on Incidence, Severity, and Impact of Treatment?
por: Caron, Benedicte, et al.
Publicado: (2020)

Immunosuppressive regimens and outcomes of inflammatory bowel disease patients requiring kidney transplantation
por: Singh, Urvashi, et al.
Publicado: (2022)

Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
por: Truta, Brindusa
Publicado: (2022)

Thiopurines are an independent risk factor for active tuberculosis in inflammatory bowel disease patients
por: Fortes, Flora Maria Lorenzo, et al.
Publicado: (2023)

Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
por: Hong, Sung Noh
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vib22an4ocrnpdoavit873e30c